Research Article
Epidemiology and Virulence Determinants including Biofilm Profile of Candida Infections in an ICU in a Tertiary Hospital in India
Table 4
Sample wise in vitro antifungal resistance profile of Candida isolates to fluconazole and amphotericin B.
| Sample | C. albicans | C. tropicalis | C. krusei | C. parapsilosis | C. kefyr | C. sphaerica | C. glabrata | FLU | AMB | FLU | AMB | FLU | AMB | FLU | AMB | FLU | AMB | FLU | AMB | FLU | AMB | SDDb no. (%) | Rc no. (%) | Rc no. (%) | SDDb no. (%) | Rc no. (%) | Rc no. (%) | SDDb no. (%) | Rc no. (%) | Rc no. (%) | SDDb no. (%) | Rc no. (%) | Rc no. (%) | SDDb no. (%) | Rc no. (%) | Rc no. (%) | SDDb no. (%) | Rc no. (%) | Rc no. (%) | SDDb no. (%) | Rc no. (%) | Rc no. (%) |
| Blood | 0 | 2 (40) | 0 | 0 | 1 (25) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 | 0 | 0 | 0 | 1 (100) | 0 | Urine | 3 (17.6) | 12 (70.6) | 2 (11.8) | 0 | 9 (60) | 0 | 0 | 1 (100) | 1 (100) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (100) | 0 | 0 | 1 (25) | 0 | Sputum | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (50) | 0 | Urinary catheter | 0 | 3 (100) | 0 | 2 (33.3) | 2 (33.3) | 0 | 0 | 0 | 0 | 0 | 1 (100) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Endotracheal tube | 0 | 0 | 0 | 0 | 4 (80) | 4 (80) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Tracheal aspirate | 0 | 10 (76.9) | 0 | 1 (9.1) | 7 (63.6) | 1 (9.1) | 1 (100) | 0 | 1 (100) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 (66.7) | 1 (33.3) | Abdominal drains | 0 | 0 | 0 | 0 | 1 (100) | 0 | 0 | 0 | 0 | 0 | 1 (100) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 (7.5) | 27 (67.5) | 2 (5) | 3 (7.1) | 24 (57.1) | 5 (11.9) | 1 (50) | 1 (50) | 2 (100) | 0 | 2 (50) | 0 | 0 | 0 | 0 | 0 | 1 (50) | 0 | 0 | 5 (45.4) | 1 (9.0) |
|
|
SDDb: susceptible dose-dependent range. Rc: resistant range. FLU: fluconazole drug. AMB: amphotericin B drug.
|